Corrigendum to "Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341-350]
1 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
2 Division of Hematology and Oncology, Ulsan University Hospital, Ulsan, South Korea.
3 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
4 Center for Breast Cancer, National Cancer Center, Goyang, South Korea.
5 Center for Breast Cancer, National Cancer Center, Goyang, South Korea; Division of Medical Oncology, Department of Internal Medicine, Korea University Guro Hospital, South Korea.
6 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: [email protected].